Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$191.17 - $325.63 $19,690 - $33,539
103 Added 9.27%
1,214 $395,000
Q4 2023

Jan 19, 2024

SELL
$160.99 - $215.69 $61,498 - $82,393
-382 Reduced 25.59%
1,111 $211,000
Q3 2023

Oct 31, 2023

BUY
$194.33 - $283.97 $7,578 - $11,074
39 Added 2.68%
1,493 $297,000
Q2 2023

Jul 25, 2023

SELL
$223.05 - $302.68 $122,008 - $165,565
-547 Reduced 27.34%
1,454 $414,000
Q1 2023

Apr 24, 2023

BUY
$175.41 - $217.92 $7,191 - $8,934
41 Added 2.09%
2,001 $433,000
Q4 2022

Jan 25, 2023

SELL
$204.38 - $296.82 $32,905 - $47,788
-161 Reduced 7.59%
1,960 $0
Q3 2022

Oct 25, 2022

BUY
$195.21 - $310.53 $7,222 - $11,489
37 Added 1.78%
2,121 $590,000
Q2 2022

Aug 04, 2022

BUY
$115.91 - $214.48 $7,186 - $13,297
62 Added 3.07%
2,084 $398,000
Q1 2022

Apr 19, 2022

BUY
$127.96 - $207.36 $258,735 - $419,281
2,022 New
2,022 $419,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.